Global Ovotransferrin Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ovotransferrin Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Ovotransferrin is a glycoprotein of egg white albumen. It has a molecular weight of 76,000 daltons and contains about 700 amino acids. Ovotransferrin makes up approximately 13% of egg albumen (in contrast to ovalbumin, which comprises 54%). As a member of the transferrin and metalloproteinase family, ovotransferrin has been found to possess antibacterial and antioxydant and immunomodulatory properties, arising primarily through its iron (Fe3+) binding capacity by locking away a key biochemical component necessary for micro-organismal survival. Bacteria starved of iron are rendered incapable of moving, making ovotransferrin a potent bacteriostatic.
Ovotransferrin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ovotransferrin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Anti-Osteoporotic and Cardiovascular Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ovotransferrin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Ovotransferrin key manufacturers include Bachem, Bioseutica, Thomas Scientific, ICL, Inc., Neova Technologies, Inc. and Dunn Labortechnik GmbH, etc. Bachem, Bioseutica, Thomas Scientific are top 3 players and held % sales share in total in 2022.
Ovotransferrin can be divided into Metal-Free Ovotransferrin and Metal-Bound Ovotransferrin, etc. Metal-Free Ovotransferrin is the mainstream product in the market, accounting for % sales share globally in 2022.
Ovotransferrin is widely used in various fields, such as Anti-Osteoporotic, Cardiovascular Disease and Others,, etc. Anti-Osteoporotic provides greatest supports to the Ovotransferrin industry development. In 2022, global % sales of Ovotransferrin went into Anti-Osteoporotic filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ovotransferrin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bachem
Bioseutica
Thomas Scientific
ICL, Inc.
Neova Technologies, Inc.
Dunn Labortechnik GmbH
Segment by Type
Metal-Free Ovotransferrin
Metal-Bound Ovotransferrin
Anti-Osteoporotic
Cardiovascular Disease
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ovotransferrin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ovotransferrin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ovotransferrin industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Ovotransferrin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ovotransferrin introduction, etc. Ovotransferrin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Ovotransferrin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Ovotransferrin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ovotransferrin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Anti-Osteoporotic and Cardiovascular Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ovotransferrin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Ovotransferrin key manufacturers include Bachem, Bioseutica, Thomas Scientific, ICL, Inc., Neova Technologies, Inc. and Dunn Labortechnik GmbH, etc. Bachem, Bioseutica, Thomas Scientific are top 3 players and held % sales share in total in 2022.
Ovotransferrin can be divided into Metal-Free Ovotransferrin and Metal-Bound Ovotransferrin, etc. Metal-Free Ovotransferrin is the mainstream product in the market, accounting for % sales share globally in 2022.
Ovotransferrin is widely used in various fields, such as Anti-Osteoporotic, Cardiovascular Disease and Others,, etc. Anti-Osteoporotic provides greatest supports to the Ovotransferrin industry development. In 2022, global % sales of Ovotransferrin went into Anti-Osteoporotic filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ovotransferrin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bachem
Bioseutica
Thomas Scientific
ICL, Inc.
Neova Technologies, Inc.
Dunn Labortechnik GmbH
Segment by Type
Metal-Free Ovotransferrin
Metal-Bound Ovotransferrin
Segment by Application
Anti-Osteoporotic
Cardiovascular Disease
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ovotransferrin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ovotransferrin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ovotransferrin industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Ovotransferrin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ovotransferrin introduction, etc. Ovotransferrin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Ovotransferrin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices